Kennedy Calls Out Deep State Corruption in Regulatory Agencies

In a recent meeting, HHS Secretary Kennedy spoke candidly about the corruption that permeates American regulatory bodies, emphasizing the need for greater transparency and oversight. His remarks highlight systemic issues and signal a shift in approach under Trump’s administration.

Health and Human Services Secretary Robert F. Kennedy Jr. is taking a firm stand against what he perceives as deep-seated corruption within the nation's regulatory agencies, echoing former President Trump’s previous assertions about the negative influence of the so-called Deep State.

In a clandestine meeting with FDA employees and newly appointed Commissioner Marty Makary, Kennedy outlined a viewpoint that resonates with many citizens: the existence of a pervasive Deep State is not merely a theory, but a tangible reality. A leaked transcript, obtained by Politico, revealed Kennedy’s comments to the officials, where he stated that the shadowy control of government policy extends far beyond notorious figures like George Soros and Bill Gates, delving instead into a concealed network of unelected bureaucrats and corporate powers who manipulate federal regulations away from public scrutiny.

Kennedy highlighted concerns surrounding the FDA’s "Generally Recognized as Safe" (GRAS) framework, labeling it a significant loophole that enables food manufacturers to bypass comprehensive safety assessments for introducing new ingredients. He announced plans for a thorough examination of the GRAS system in March, asserting that true transparency and stringent oversight are vital for the public's welfare, as opposed to automatic endorsements that primarily benefit corporate interests.

Moreover, he emphasized that this issue of industry influence stretches across the board, stating in remarks reported by NBC News that “every agency” had succumbed to similar vulnerabilities.

During his 2024 campaign, Kennedy has consistently voiced his opinion about bureaucratic profiteering, even cautioning FDA personnel just days before the election to “preserve your records and pack your bags” if they were part of what he had termed a “corrupt system.” Now, with Trump reinstated in the White House and Kennedy leading HHS, their initiatives are not merely focused on rhetoric about draining the swamp, but rather aim to address the very agencies initially instituted to safeguard public welfare, yet have instead prioritized corporate profit.